Inspire Medical Systems, Inc. (INSP) has a MoatMap StockRank of 61/100 based on Quality (78/100), Value (60/100), and Momentum (7/100) factor scores. The current signal is HOLD. While a high-growth medical device company, it does not align with our core 18-month macro themes and lacks the valuation margin of safety required by the Buffett lens.
Inspire Medical Systems, Inc. is a medical technology company specializing in the development and commercialization of a minimally invasive neurostimulation device for obstructive sleep apnea (OSA). Its significant competitive moat stems from its Inspire system being the first and only FDA-approved implantable device for moderate-to-severe OSA, establishing a strong first-mover advantage. The company targets a large addressable market of patients who cannot tolerate traditional OSA therapies.
| Price | $42.21 |
| Market Cap | $1.2B |
| P/E (TTM) | 9.59 |
| P/E (Forward) | 32.32 |
| Price/Book | 1.53 |
| Return on Equity | 18.4% |
| Return on Invested Capital | 8.1% |
| Debt/Equity | 3.73 |
| Gross Margin | 85.8% |
| Operating Margin | -0.5% |
| Revenue Growth | 1.6% |
| Free Cash Flow | $86M |
Inspire Medical Systems, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).